What’s Next in the GLP-1 Era?
We aren’t surprised that nearly 1 in 4 search entries in the RxSS member portal are GLP-1 and related medications. ...
- Select Category
- Chronic Conditions
- Engagement
- Events
- Healthcare Costs
- Media
- Medication Adherence
- Member Stories
- Our Team
- Privacy and Security
- Product
- Success Stories
- Thought Leadership
- Transparency
- Uncategorized
- Select Category
- Chronic Conditions
- Engagement
- Events
- Healthcare Costs
- Media
- Medication Adherence
- Member Stories
- Our Team
- Privacy and Security
- Product
- Success Stories
- Thought Leadership
- Transparency
- Uncategorized
The Adderall Shortage Is Real – Here’s How RxSS Helps Members
We know many members are scrambling to find pharmacies with the common ADHD medication in ...
Humira Biosimilars and other Biologic Alternatives
A wave of FDA-approved biosimilars for Humira and other costly biologics will enter the U.S. ...
Prescription Drug Options – Pharmacist Curated, Doctor Approved
Members shouldn't confuse our clinical suggestions for intervention. Medication decisions are between patient and doctor. ...
Considering a PBM’s Savings Tool? 10 Questions to Ask Right Now
Free PBM tools can help members get more from their pharmacy benefits, maybe even save ...
Drug Cost Comparison Tools and Healthcare Cost Transparency Come to Life
Seemingly since the beginning of time, consumers have rarely known what a doctor visit, medical ...
Specialty Copay Programs – Accumulate, Maximize or Avoid?
Utilization of specialty medications continues to rise, and so do costs for patients and plan ...
Why Are the Most Important Rx Decision-makers Still in the Dark?
The only people who can write prescriptions typically have no idea what patients will pay ...
Let’s Talk About Mental Health
Every May we raise awareness about mental health as we continue to help our members ...
Success With Point Benefit Solutions Hinges on the Pharmacy Factor
Many point benefits solutions have produced positive results for employers and health plans. However, their ...
Stay COnnected
Share your email and once a month we’llsend you industry news and insights.
